MarkWide Research

Sale!

Pen Needles Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 172
Delivery Format: PDF + Excel

$2,950.00

At a CAGR rate of 11.2%, the pen needles market will reach USD 2.2 billion by 2026 from USD 1.3 million in 2021. The favorable reimbursement policies in certain countries and the growing prevalence of chronic diseases drive the market’s growth. The market’s growth will be impeded by the demand for other delivery methods, low reimbursement in developing countries, and needle anxiety. The market faces challenges such as misuse of insulin pens and reusing pen needles. There are opportunities in the market due to growing preferences for biosimilar drugs and emerging markets.

Global Pen Needles Market Impact of COVID-19

COVID-19 patients are at greater risk of death and hospitalization due to hypertension, type 2 diabetes, and CVD. These comorbidities have become more critical for patients who already have them and those who are most at risk. Healthcare professionals and patients are more aware of this and have supported the growth in the market for management devices. Both hypoglycemia and hyperglycemia can lead to adverse outcomes for hospitalized patients. Patients with diabetes and SARS CoV-2 infection should have optimal glycemic control to lower the risk of COVID-19 severe complications. Insulin and GLP-1RAs may be a viable therapeutic option for COVID-19 patients who are asymptomatic but not critically ill. Customized therapies have been necessary for strict glucose monitoring, insulin, and anti-diabetic drug dosage adjustments. For optimal diabetes management, the adoption of continuous glucose monitoring devices, insulin pumps, insulin pens, and insulin pumps has increased. Diabetes management is a complex process that requires pen needles in large numbers. These would be affected by any changes in product or service demand.

Driver: Growing prevalence and severity of chronic diseases

In the past few years, chronic diseases have significantly increased in prevalence. These diseases, including diabetes, osteoporosis, cardiovascular disease (CVD), and multiple sclerosis, require daily or weekly drug administration. Typically, pen injectors are used. Pen injectors are the new standard in injectable drug delivery systems. Because they are simple, reliable, and can be administered directly by patients without the assistance of a doctor, pen injectors have enjoyed immense popularity. Pen injectors include a pen needle, which is a removable attachment. The needle must be long and sharp to ensure the medication reaches the target tissues. Pen needle technology has become more critical due to the increasing prevalence of chronic diseases. This ensures that patients are more willing to comply with treatments and manage their patient population better.

Restraint: Preference to other modes of drug delivery

Pen needles can be a hassle-free and easy way to deliver drugs. However, needlestick injuries, infections, hyperglycemia, pain, and needlestick injuries are all possible. Some patients may experience hyperglycemia from insulin pen therapy since the dose can’t be controlled. Because insulin pumps can perform automated insulin suspension and lower the risk of hypoglycemia, there has been an evolution in diabetes treatment in Europe. This is a significant factor that has slowed market growth. This issue has been addressed to a certain extent by needle-free drug delivery technology, but its application in therapeutic areas remains limited.

Opportunities: Biosimilar drugs are gaining popularity

Many pharmaceutical companies, including Sandoz (Germany), Teva Pharmaceutical Industry Ltd. (Israel), and JCR Pharmaceuticals Co. Ltd. (Japan), introduced biosimilars in 2006. Biosimilars are more popular than their patent counterparts due to their lower cost. Biosimilars will be even more popular due to the imminent expiration of many biologic molecules’ patents.

Even governments and insurance companies are encouraging the use of generics and biosimilars. CVS Caremark, the US’s largest prescription insurance company, has replaced injectable drugs like EpiPen by Mylan and Lantus by Sanofi with biosimilars Basaglar (injection pen) and Adrenaclick, an autoinjector, by Amedra Pharmaceuticals. Basaglar can be administered by a pen injector, which favors pen needles. Pen injection is used for many other injectable drugs. This will increase the market’s potential for growth.

Challenge: Reuse pen needles

Needles are reused in many parts of the globe. The extent of needle reuse varies from as little as 30% to as high as 95%. A study published in Value Health Journal found that around 98.35% of patients use insulin pen needles from China.

This is due to three main reasons: unaffordability, insufficient reimbursements in many developing nations, and convenience. Market growth is affected by the high rate of reused pen needles. This reduces the demand for new needles. A study by the Moscow Regional Research Clinical Institute revealed that pen needles were contaminated with bacteria after use and that needles prone to bacterial growth increased with each reuse. Pen needle reuse can cause multiple complications, including infection, poor glycemic control, and lipohypertrophy. This raises safety concerns.

North America will be the market leader in pen needles by 2020.

North America was the dominant market for pen needles. Market growth is being driven by the growing prevalence of diabetes and favorable reimbursement for pen needles. Federal initiatives to increase awareness about injection techniques, increased market penetration by top players, and improved pen needle technology is all driving US market growth.

Pen Needles Market Report Scope and Segmentation

ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Market Players

Becton, Dickinson, and Company (US), Novo Nordisk A/S(Denmark), Ypsomed Holding AG/S (Switzerland), Owen Mumford (UK), Terumo Corporation/Japan), Nipro Corporation/Japan), Allison Medical (US), AdvaCare Pharmaceutical (the US), GlucoRx/UK), Berpu Medical Technology/China, ARKRAY/Japan), GlucoRx/UK, HTL-S Medical Products (US), Simple Diagnostics (US), Iyon in Turkey), Links Medical Products, and MHC Medical Products (US), and MHC Medical Products, Iyon (Turkey), and Links Medical Products (US), and MHC Medical Products, MHC Medical Products (US), and MHC Medical Products, MHC Medical Products (US), and MHC Medical Products, MHC Medical Products (USA), and MHC Medical Products, and MHC Medical Products, and MHC Medical Products, MHC Medical Products, and MHC Medical Products, and MHC Medical Products, and MHC Medical Products, and MHC Medical Products, MHC Medical Products, USA), and MHC Medical Products, and MHC Medical Products, respectively).

 

The market for pen needles worldwide, by product type.

  • Standard pen needles
  • Safety pen needles

The market for pen needles worldwide is sorted by length.

  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

The market for pen needles worldwide, according to therapy.

  • Insulin therapy
  • Therapy with Glucagon-like Peptide-1(GLP-1)
  • Growth hormone therapy
  • Other therapies

The market for pen needles worldwide is sorted by mode of purchase.

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

Table of Contents

1 INTRODUCTION (Page No. – 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.3.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 32)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (PEN NEEDLES MARKET)
2.2 MARKET SIZE ESTIMATION
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY (2020)
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PEN NEEDLES MARKET (2020)
FIGURE 8 DEMAND-SIDE ANALYSIS
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PEN NEEDLES MARKET (20212026)
FIGURE 11 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: PEN NEEDLES MARKET

3 EXECUTIVE SUMMARY (Page No. – 45)
FIGURE 13 PEN NEEDLES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 PEN NEEDLES MARKET, BY LENGTH, 2021 VS. 2026 (USD MILLION)
FIGURE 15 PEN NEEDLES MARKET, BY THERAPY, 2021 VS. 2026 (USD MILLION)
FIGURE 16 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET

4 PREMIUM INSIGHTS (Page No. – 49)
4.1 PEN NEEDLES MARKET OVERVIEW
FIGURE 18 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET
4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY AND COUNTRY
FIGURE 19 JAPAN DOMINATES THE APAC MARKET
4.3 PEN NEEDLES MARKET: GEOGRAPHIC MIX
FIGURE 20 INDIA & CHINA TO WITNESS THE HIGHEST GROWTH IN THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 52)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of chronic diseases
FIGURE 22 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE US, 19952030 (MILLION INDIVIDUALS)
FIGURE 23 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040
5.2.1.2 Favorable reimbursement in select countries
5.2.2 RESTRAINTS
5.2.2.1 Preference for alternative modes of drug delivery
5.2.2.2 Poor reimbursement scenario in developing countries
5.2.2.3 Needle anxiety
5.2.3 OPPORTUNITIES
5.2.3.1 Growing preference for biosimilar drugs
5.2.3.2 Emerging markets
TABLE 2 RISING INCOME LEVELS IN EMERGING COUNTRIES
5.2.4 CHALLENGES
5.2.4.1 Reuse of pen needles
5.2.4.2 Misuse of injection pens
5.3 PRICING ANALYSIS
TABLE 3 PRICING OF PEN NEEDLES AVAILABLE IN THE MARKET
5.4 VALUE CHAIN ANALYSIS
FIGURE 24 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM MARKET MAP
FIGURE 25 PEN NEEDLES MARKET: ECOSYSTEM MARKET MAP
5.6 PORTERS FIVE FORCES ANALYSIS
TABLE 4 PEN NEEDLES MARKET: PORTERS FIVE FORCES ANALYSIS
5.6.1 INTENSITY OF COMPETITIVE RIVALRY
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 THREAT OF NEW ENTRANTS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 26 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS
5.8 REGULATORY ANALYSIS
5.8.1 NORTH AMERICA
5.8.1.1 US
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 27 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
5.8.2 EUROPE
FIGURE 28 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
5.8.3 ASIA PACIFIC
5.8.3.1 Japan
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.8.3.2 China
TABLE 9 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.8.3.3 India
5.9 IMPACT OF COVID-19 ON THE PEN NEEDLES MARKET
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES
FIGURE 29 PATENT PUBLICATION TRENDS (2011MAY 2021)
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLES PATENTS (JANUARY 2011JUNE 2021)
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR PEN NEEDLE PATENTS (JANUARY 2011JUNE 2021)
5.11 TECHNOLOGY ANALYSIS
5.11.1 KEY TECHNOLOGY
5.11.1.1 Fluid flow enhancement technology
5.11.2 COMPLEMENTARY TECHNOLOGY
5.11.2.1 Microfabricated needles
5.11.3 ADJACENT TECHNOLOGY
5.11.3.1 Autoinjectors

6 PEN NEEDLES MARKET, BY TYPE (Page No. – 73)
6.1 INTRODUCTION
TABLE 11 PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 12 PEN NEEDLES MARKET, BY TYPE, 20192026 (MILLION UNITS)
6.2 STANDARD PEN NEEDLES
6.2.1 STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE
TABLE 13 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 14 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 15 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 20192026 (MILLION UNITS)
6.3 SAFETY PEN NEEDLES
6.3.1 GROWING CONCERN OVER NEEDLESTICK INJURIES DRIVES THE GROWTH OF SAFETY PEN NEEDLES
TABLE 16 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 17 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 18 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 20192026 (MILLION UNITS)

7 PEN NEEDLES MARKET, BY LENGTH (Page No. – 80)
7.1 INTRODUCTION
TABLE 19 PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
7.2 8MM
7.2.1 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
TABLE 20 8MM PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 21 8MM PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.3 5MM
7.3.1 5MM PEN NEEDLES TO REGISTER SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD
TABLE 22 5MM PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 23 5MM PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.4 6MM
7.4.1 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE
TABLE 24 6MM PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 25 6MM PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.5 4MM
7.5.1 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
TABLE 26 4MM PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 27 4MM PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.6 12MM
7.6.1 THE POPULARITY OF SHORTER & LESS PAINFUL NEEDLES HAMPERS THE GROWTH OF THE 12MM PEN NEEDLES MARKET
TABLE 28 12MM PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 29 12MM PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.7 10MM
7.7.1 AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET
TABLE 30 10MM PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 31 10MM PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)

8 PEN NEEDLES MARKET, BY THERAPY (Page No. – 91)
8.1 INTRODUCTION
TABLE 32 PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
8.2 INSULIN THERAPY
8.2.1 RISING PREVALENCE OF DIABETES DRIVES THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY
TABLE 33 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 20192026 (USD MILLION)
8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY
8.3.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS TO DRIVE MARKET GROWTH
TABLE 34 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 20192026 (USD MILLION)
8.4 GROWTH HORMONE THERAPY
8.4.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY
TABLE 35 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 20192026 (USD MILLION)
8.5 OTHER THERAPIES
TABLE 36 PEN NEEDLES MARKET FOR OTHER THERAPIES, BY COUNTRY, 20192026 (USD MILLION)

9 PEN NEEDLES MARKET, BY MODE OF PURCHASE (Page No. – 98)
9.1 INTRODUCTION
TABLE 37 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
9.2 RETAIL
9.2.1 RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES
TABLE 38 PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY COUNTRY, 20192026 (USD MILLION)
9.3 NON-RETAIL
9.3.1 LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT
TABLE 39 INDICATIVE LIST OF REGULATIONS
TABLE 40 PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY COUNTRY, 20192026 (USD MILLION)

10 PEN NEEDLES MARKET, BY REGION (Page No. – 103)
10.1 INTRODUCTION
TABLE 41 PEN NEEDLES MARKET, BY REGION, 20192026 (USD MILLION)
FIGURE 32 EMERGING COUNTRIES ARE EXPECTED TO WITNESS HIGHER GROWTH OVER THE FORECAST PERIOD
10.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 43 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 44 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 45 NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 46 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.2.1 US
10.2.1.1 The US dominates the global pen needles market
FIGURE 34 TOTAL FERTILITY RATE IN THE US POPULATION (1990-2020)
TABLE 47 US: KEY MACROINDICATORS
TABLE 48 US: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 49 US: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 50 US: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 51 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Unfavorable regulatory processes in Canada to restrain the market growth
TABLE 52 CANADA: KEY MACROINDICATORS
TABLE 53 CANADA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 54 CANADA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 55 CANADA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 56 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.3 EUROPE
TABLE 57 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 58 EUROPE: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 59 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 60 EUROPE: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 61 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 High diabetes expenditure and reimbursement for pen needles is expected to drive the market in Germany
TABLE 62 GERMANY: KEY MACROINDICATORS
TABLE 63 GERMANY: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 64 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 65 GERMANY: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 66 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Favorable health insurance system to drive the pen needles market in France
TABLE 67 FRANCE: KEY MACROINDICATORS
TABLE 68 FRANCE: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 69 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 70 FRANCE: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 71 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION) 20192026 (USD MILLION) 120
10.3.3 UK
10.3.3.1 NHS support and access to cost-effective pen needles are likely to drive the market in the UK
TABLE 72 UK: KEY MACROINDICATORS
TABLE 73 UK: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 74 UK: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 75 UK: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 76 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Regional variation in terms of coverage and benefits to hinder the market growth
TABLE 77 ITALY: KEY MACROINDICATORS
TABLE 78 ITALY: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 79 ITALY: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 80 ITALY: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 81 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Supportive regulations mandating the use of safety pen needles to boost the growth of the Spanish market
TABLE 82 SPAIN: KEY MACROINDICATORS
TABLE 83 SPAIN: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 84 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 85 SPAIN: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 86 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 87 ROE: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 88 ROE: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 89 ROE: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 90 ROE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 35 APAC: PEN NEEDLES MARKET SNAPSHOT
TABLE 91 APAC: PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 92 APAC: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 93 APAC: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 94 APAC: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 95 APAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 High diabetes incidence and supportive reimbursement policies to drive the market growth in Japan
TABLE 96 JAPAN: KEY MACROINDICATORS
TABLE 97 JAPAN: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 98 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 99 JAPAN: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 100 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Large patient population and healthcare infrastructure improvements to drive the market growth in China
TABLE 101 CHINA: KEY MACROINDICATORS
TABLE 102 CHINA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 103 CHINA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 104 CHINA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 105 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4.3 AUSTRALIA AND NEW ZEALAND
10.4.3.1 Growing geriatric population in Australia and New Zealand to drive the pen needles market
TABLE 106 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 107 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 108 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 109 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Healthcare infrastructural improvements and implementation of favorable government initiatives support the market in India
TABLE 110 INDIA: KEY MACROINDICATORS
TABLE 111 INDIA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 112 INDIA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 113 INDIA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 114 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Growing chronic diseases in the geriatric population augments the growth of the pen needles market
TABLE 115 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 116 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 117 SOUTH KOREA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 118 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4.6 SOUTHEAST ASIA
10.4.6.1 Growing awareness about diabetes drives the pen needles market
FIGURE 36 GROWING PREVALENCE OF DIABETES IN SOUTHEAST ASIA
FIGURE 37 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018)
FIGURE 38 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION)
TABLE 119 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 120 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 121 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 122 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.4.7 REST OF APAC
TABLE 123 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 124 ROAPAC: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 125 ROAPAC: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 126 ROAPAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 127 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 128 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 129 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 130 LATIN AMERICA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 131 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil dominates the pen needles market in Latin America
TABLE 132 BRAZIL: KEY MACROINDICATORS
TABLE 133 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 134 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 135 BRAZIL: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 136 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increasing incidence of lifestyle-related disorders and rising awareness drive market growth in Mexico
TABLE 137 MEXICO: KEY MACROINDICATORS
TABLE 138 MEXICO: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 139 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 140 MEXICO: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 141 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
FIGURE 39 HEALTH EXPENDITURE IN LATIN AMERICAN COUNTRIES IN 2018 (% GDP)
TABLE 142 ROLA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 143 ROLA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 144 ROLA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 145 ROLA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)
10.6 MIDDLE EAST AND AFRICA
10.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY MAY SUPPORT MARKET GROWTH
TABLE 146 MEA: PEN NEEDLES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 147 MEA: PEN NEEDLES MARKET, BY LENGTH, 20192026 (USD MILLION)
TABLE 148 MEA: PEN NEEDLES MARKET, BY THERAPY, 20192026 (USD MILLION)
TABLE 149 MEA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 20192026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. – 155)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PEN NEEDLES MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 41 PEN NEEDLES MARKET SHARE, BY KEY PLAYER, 2020
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 42 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT (2020)
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 STARTING BLOCKS
11.6.4 RESPONSIVE COMPANIES
FIGURE 43 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
11.7 COMPANY PRODUCT FOOTPRINT
TABLE 150 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET
TABLE 151 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY LENGTH
TABLE 152 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY THERAPY
11.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 153 GEOGRAPHIC REVENUE MIX: PEN NEEDLES MARKET (2020)
11.9 COMPETITIVE

Segmentation

By product type

  • Standard pen needles
  • Safety pen needles

By length

  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

By therapy

  • Insulin therapy
  • Glucagon-like Peptide-1 (GLP-1) therapy
  • Growth hormone therapy
  • Other therapies

Major Companies

Becton, Dickinson, and Company (US), Novo Nordisk A/S(Denmark), Ypsomed Holding AG/S (Switzerland), Owen Mumford (UK), Terumo Corporation/Japan), Nipro Corporation/Japan), Allison Medical (US), AdvaCare Pharmaceutical (the US), GlucoRx/UK), Berpu Medical Technology/China, ARKRAY/Japan), GlucoRx/UK, HTL-S Medical Products (US), Simple Diagnostics (US), Iyon in Turkey), Links Medical Products, and MHC Medical Products (US), and MHC Medical Products, Iyon (Turkey), and Links Medical Products (US), and MHC Medical Products, MHC Medical Products (US), and MHC Medical Products, MHC Medical Products (US), and MHC Medical Products, MHC Medical Products (USA), and MHC Medical Products, and MHC Medical Products, and MHC Medical Products, MHC Medical Products, and MHC Medical Products, and MHC Medical Products, and MHC Medical Products, and MHC Medical Products, MHC Medical Products, USA), and MHC Medical Products, and MHC Medical Products, respectively).

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF